Jiebo Huang

164 LanXi Road
Shanghai, 200062, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A single-center retrospective cohort study of cinacalcet efficacy in uremic hemodialysis patients: Correlations with changes in parathyroid hormone, calcium and phosphorus over 12 months.

A single-center retrospective cohort study of cinacalcet efficacy in uremic hemodialysis patients: Correlations with changes in parathyroid hormone, calcium and phosphorus over 12 months.

Journal: Pakistan journal of pharmaceutical sciences

Published: August 23, 2026

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Journal: Journal of diabetes research

Published: April 17, 2025

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Journal: Journal of diabetes research

Published: April 17, 2025

Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.

Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.

Journal: BMC nephrology

Published: March 05, 2025

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Unveiling the Therapeutic Potential of Suyin Detoxification Prescription in Diabetic Nephropathy: A Comprehensive Study Integrating Clinical Efficacy, Network Pharmacology, and Molecular Mechanisms.

Journal: Journal of diabetes research

Published: January 01, 2025

Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.

Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.

Journal: Inflammation

Published: October 20, 2024

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment.

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment.

Journal: Archives of pharmacal research

Published: March 25, 2024

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.

Journal: Journal of diabetes research

Published: October 18, 2021

Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.

Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.

Journal: Biochemical and biophysical research communications

Published: October 17, 2020

Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.

Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.

Journal: Life sciences

Published: August 03, 2020

ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.

ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.

Journal: Biochemical and biophysical research communications

Published: March 25, 2020

High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.

High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.

Journal: Experimental cell research

Published: May 09, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026